TWO · Healthcare

Prince Pharmaceutical Co., Ltd. (6935)

Drug Manufacturers - Specialty & Generic

Prince Pharmaceutical Co., Ltd. (6935) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $1.04B, P/E ratio is 10.61, net margin is -1.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 6935

Market cap
$1.04B
P/E ratio
10.61
Gross profit (TTM)
$116.94M
Net margin
-1.4%

Prince Pharmaceutical Co., Ltd. (6935) — FAQ

What is Prince Pharmaceutical Co., Ltd.'s market cap?

Prince Pharmaceutical Co., Ltd. (6935) has a reported market cap of $1.04B (data as of 2026-03-29).

What is 6935's P/E ratio?

The price-to-earnings (P/E) ratio for Prince Pharmaceutical Co., Ltd. (6935) is 10.61 (data as of 2026-03-29).

Does Prince Pharmaceutical Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Prince Pharmaceutical Co., Ltd. (6935). Check the MyAverix Finance app for the latest dividend data.

What sector is Prince Pharmaceutical Co., Ltd. in?

Prince Pharmaceutical Co., Ltd. (6935) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 6935 listed on?

6935 is listed on TWO.

What is Prince Pharmaceutical Co., Ltd.'s net margin?

Prince Pharmaceutical Co., Ltd. (6935) reports a net margin of -1.4% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play